Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Prediction and Prevention of Inflammatory Bowel Disease

Author:

Torres Joana12,Halfvarson Jonas3,Rodríguez-Lago Iago4ORCID,Hedin Charlotte R H56ORCID,Jess Tine78,Dubinsky Marla9,Croitoru Kenneth1011,Colombel Jean-Frédéric12ORCID

Affiliation:

1. Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Portugal

2. Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal

3. Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

4. Department of Gastroenterology, Hospital de Galdakao, and Biocruces Bizkaia Health Research Institute, Bilbao, Spain

5. Karolinska Institutet, Department of Medicine Solna, Stockholm, Sweden

6. Karolinska University Hospital, Gastroenterology unit, Department of Gastroenterology, Dermatovenereology and Rheumatology, Stockholm, Sweden

7. Department of Epidemiology Research, Statens Serum Institut, Copenhagen S, Denmark

8. PREDICT, Institute of Clinical Medicine, Aalborg University, Aalborg, Denmark

9. Division of Pediatric Gastroenterology and Nutrition, Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, Icahn School of Medicine Mount Sinai, New York, NY, USA

10. Center for Inflammatory Bowel Disease, Mount Sinai Hospital, Toronto, ON, Canada

11. Division of Gastroenterology and Hepatology, University of Toronto, Toronto, ON, Canada

12. Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Abstract

Abstract Inflammatory bowel disease [IBD] is a complex chronic disorder with no clear aetiology and no known cure. Despite recent advances in overall disease management and improved therapeutics, patients with IBD still experience a substantial burden. Furthermore, as the incidence continues to increase in developing areas of the world, it is expected that the burden of IBD to society will increase and exert tremendous pressure on health care systems worldwide. Therefore, new strategies to prevent the global increase of IBD are urgently required. Data are being progressively acquired on the period preceding disease diagnosis, which support the concept that IBD has a preclinical period that may reveal the triggers of disease and may be amenable to early intervention. Having a better knowledge of this preclinical period will increase the potential not only for improved understanding of disease pathogenesis and improved therapeutics, but also for disease prediction and prevention.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3